National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 68353 [2020-23880]
Download as PDF
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; R13 Conference Grant
Review.
Date: November 17–18, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1078, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1078, Bethesda, MD 20892, 301–594–7319,
khanr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 23, 2020.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Harnessing Natural Killer
(NK) Cells to Prevent, Control, or Eradicate
HIV (R01 Clinical Trial Not Allowed).
Date: November 23–24, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Kumud K. Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, Rockville, MD
20892, 301–761–7830, kumud.singh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 23, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23880 Filed 10–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2020–0317]
[FR Doc. 2020–23881 Filed 10–27–20; 8:45 am]
Commercial Diving Operations—
Equivalent Levels of Safety Policy
Letter
BILLING CODE 4140–01–P
Coast Guard, DHS.
Notice of availability.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
SUMMARY:
ACTION:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
The Coast Guard is
announcing the availability of CG–OES
Policy Letter 02–20, Commercial Diving
Operations—Equivalent Levels of
Safety. This policy letter provides
guidance on Coast Guard acceptance of
certain industry-recognized standards
for commercial diving operations as
providing a level of safety that is
equivalent to the requirements
contained in Coast Guard regulations.
DATES: This policy is applicable October
28, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have questions or feedback related
to this policy, contact Mr. Ken A. Smith,
Vessel and Facility Operating Standards
Division (CG–OES–2), Coast Guard;
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
68353
telephone 202–372–1413, email
Ken.A.Smith@uscg.mil.
SUPPLEMENTARY INFORMATION:
I. Abbreviations
ADCI Association of Diving Contractors
International
CFR Code of Federal Regulations
DHS Department of Homeland Security
FR Federal Register
IMCA International Marine Contractors
Association
U.S.C. United States Code
II. Discussion
The Coast Guard’s requirements for
commercial diving are found in Title 46
of the Code of Federal Regulations
(CFR), part 197, subpart B. Based on
data obtained by the Coast Guard in
2014, the majority of commercial diving
operators subject to these requirements
were members of commercial diving
organizations that have established
commercial diving standards.1 As
members of these organizations, these
operators have committed to complying
with the standards established by their
organizations.
These organizations have made
improvements over the years, such as in
the training and qualification
requirements of commercial divers,
medical examinations, and procedures
associated with the different modes of
diving, that have made commercial
diving operations safer. The Association
of Diving Contractors International
(ADCI) and the International Marine
Contractors Association (IMCA)
contacted the Coast Guard and
requested that we review their standards
and issue a Commercial Diving
Operations—Equivalent Levels of Safety
Policy Letter. The Coast Guard has
completed the review and is issuing
CG–OES Policy Letter 02–20,
Commercial Diving Operations—
Equivalent Levels of Safety.
In summary, CG–OES Policy Letter
02–20 provides that the Coast Guard
considers commercial diving operations
being performed in accordance with
ADCI International Consensus
Standards for Commercial Diving and
Underwater Operations, edition 6.3
(2016) 2 and IMCA International Code of
Practice for Offshore Diving (IMCA D
1 U.S. Coast Guard, ‘‘Commercial Diving
Operations: Notice of Proposed Rulemaking
Preliminary Regulatory Analysis and Initial
Regulatory Flexibility Analysis,’’ table 2–3, page 25
(Dec. 2014), (available at https://
www.regulations.gov/document?D=USCG-19983786-0195.
2 Available at https://www.adc-int.org/
content.asp?contentid=173.
E:\FR\FM\28OCN1.SGM
28OCN1
Agencies
[Federal Register Volume 85, Number 209 (Wednesday, October 28, 2020)]
[Notices]
[Page 68353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23880]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Harnessing Natural Killer (NK) Cells
to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not
Allowed).
Date: November 23-24, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Kumud K. Singh, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892, 301-761-7830, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 23, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-23880 Filed 10-27-20; 8:45 am]
BILLING CODE 4140-01-P